If the Aim Is to Lower Drug Prices, Who Is in the Crosshairs? If the Aim Is to Lower Drug Prices, Who Is in the Crosshairs?

Many entities ' opaque practices have led to criticism that businesses -- from manufacturers to insurers to pharmacy benefit managers -- are pocketing savings that should be accruing to patients.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news